few days ago we raised the dilemma of how to understand pharmaceutical expenditure, whether as a problem of economic management and public health problem.
Today we have a clear example of how the administration resolves the dilemma: cheaper drugs.
But would not it be necessary to know if prescribed properly? Ie, is used in cases to be used or prescribed for minor symptoms often? and a step beyond, are effective drugs that the health system should be kept low or free prescription should be more regulated?
Today we have a clear example of how the administration resolves the dilemma: cheaper drugs.
At this point, I have no means clear that the defense of freedom of limitations is only a professional need, sometimes I have a feeling that is something that the pharmaceutical industry also plays with a purely profit and on which structures its entire business strategy
0 comments:
Post a Comment